Manifold MarketsSem KYCDados de resolução verificadosRazoavelmente calibradoPrevisão da comunidade atualPortugal 94%Líder entre 13 opções
Previsores
17
Tipo de pergunta
multiple choice
Metodologia
Play-money forecasting platform
Tipo de fonte
Previsão
Variação 7d
0.0 pts
Dados do mercado
Atualizado há 8 horas
Desatualizado27/03/24, 19:24 UTC31/12/29, 22:59 UTC
Tendências
Regras
This market resolves Yes to each country that legalizes the use of one or more psychedelic substances between market creation and market close, including cases in which such use is contingent on prescription by a licensed medical professional.
- At the time of market creation, studies on the efficacy of psychedelic substances in mental health treatments are being conducted by various institutes globally.
- Several countries have shown interest in exploring the therapeutic potential of psychedelics, with promising results emerging in the treatment of addiction, schizophrenia, depression, and other disorders.
- Some of the countries listed as options already allow the use of some psychedelics in some or all settings.
- For example, Australia has legalized the prescription of MDMA and psylocibin effective Jul 1, 2023.
- In Germany, ibogaine is legal while other psychedelics remain illegal.
